Atezolizumab Plus nab-Paclitaxel in the Treatment of Metastatic Triple-Negative Breast Cancer With 2-Year Survival Follow-up

2018279 citationsJournal Articlebronze Open Access

Authors

ClinicalTrials.gov identifier: NCT01633970.

Good health and well-being

Published in: JAMA Oncology

Volume 5, Issue 3, pp. 334-334

Field-Weighted Citation Impact: 12.95